Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
First-time investors can benefit greatly from expert advice. Learn key strategies to navigate the investment landscape effectively.
28,248 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
Lam Research shares jump on stronger AI-related demand for semiconductor equipment. With foundries expanding capacity...
Bitcoin holds near the key $82,000 level as Pi Network’s PI token exits the top 50 alts. The move highlights liquidit...
Palantir's 2025 results set a high-growth trajectory, but investors want to know how the stock could perform by 2030....
Whales keep piling into Bitcoin as volatility persists. A rising number of 100+ BTC wallets points to sustained inter...
As Wall Street eyes the next stock split, ASML, Lilly, and TransDigm sit near the top of the list. Analysts say the o...
Jim Cramer defies the pullback, urging investors to buy DoorDash despite a roughly 30% year-to-date drop. The call hi...
NIO posted a 62% year-over-year jump in May deliveries, sending stock higher as it rolls out new models. Tesla edged ...
NVIDIA and SK hynix announce a deeper partnership to secure high-bandwidth memory amid Jensen Huang's warning that th...
May CPI rose 4.2% year over year, driven by energy shocks but core inflation stayed stubborn. Markets wrestle with wh...
Crypto markets surged as talk of a potential Iran truce revived risk appetite. Ripple and Ethereum led gains, with Bi...